Tonghua Huaxia Pharmaceutical

Tonghua Huaxia Pharmaceutical is a Chinese pharmaceutical company based in Tonghua, Jilin Province, specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. Founded in 1967 as a state-owned enterprise and restructured in 2000, the company has established a strong presence in therapeutic areas such as diabetes, cardiovascular diseases, and cerebrovascular disorders. Its flagship products include Xiao-Ke-An capsules for diabetes, Compound Dan Zhi tablets for ischemic stroke, and KuDieZi Injection for vascular conditions. The company operates as part of the Tonghua Huaxia Group and maintains a focus on integrating traditional herbal knowledge with modern pharmacological research. It possesses comprehensive manufacturing capabilities for oral solids and injections, adhering to GMP standards.